Researchers have made significant progress in understanding how proteins acquire their complex three-dimensional shapes, a process known as protein folding. This fundamental biological mystery is crucial because a protein's shape dictates its function. The study utilized advanced computational models and experimental techniques to identify key principles governing the folding process, including the role of amino acid sequences and environmental factors. This breakthrough has implications for drug discovery, disease understanding, and biotechnology, as misfolded proteins are linked to various ailments.
- Researchers are unraveling the mystery of how proteins acquire their 3D shapes (protein folding).
- A protein's shape is fundamental to its function in biological processes.
- Advanced computational models and experimental techniques were used in the study.
The government has announced that all kin of deceased organ donors will now receive priority in organ transplant allocations, regardless of their state of domicile. This policy change aims to encourage organ donation by recognizing the altruistic act of donor families. Previously, priority was often limited by geographical boundaries. The new rule, applicable nationwide, seeks to increase the availability of organs and streamline the allocation process, promoting a more equitable and efficient organ transplant system.
- Kin of deceased organ donors will now get priority in organ transplant allocations.
- This priority is nationwide, irrespective of the state of domicile.
- The policy aims to encourage organ donation by recognizing donor families' altruism.
The National Medical Register (NMR) ID registration for doctors will now be managed by the National Medical Commission (NMC) through its Ethics and Medical Registration Board (EMRB). Previously handled by the erstwhile Medical Council of India, this change aims to streamline the registration process and maintain a comprehensive database of medical professionals. The NMR ID is crucial for doctors to practice and for regulatory oversight, ensuring accountability and transparency in the medical fraternity.
- National Medical Register (NMR) ID registration for doctors is now under NMC's EMRB.
- The change aims to streamline registration and maintain a comprehensive database.
- NMR ID is crucial for doctors' practice and regulatory oversight.
The Delhi High Court has directed the Delhi government to issue a show-cause notice and provide an opportunity for a hearing before terminating the services of employees at Mohalla Clinics. The ruling came in response to petitions filed by staff members whose contracts were abruptly terminated. The court emphasized the principles of natural justice, ensuring that employees have a fair chance to present their case. This decision provides crucial protection for contractual workers and highlights the judiciary's role in upholding labor rights.
- Delhi High Court mandated prior notice and hearing before terminating Mohalla Clinic staff.
- The ruling upholds principles of natural justice for contractual employees.
- It provides protection against arbitrary termination of services for workers.
Kerala is developing a new draft policy for the elderly, aiming to ensure their rights, dignity, and active participation in society. The policy proposes a job registry for senior citizens, temporary shelters for those facing abuse or neglect, and a comprehensive social security framework. It emphasizes inter-generational bonding, accessible infrastructure, and protection against abuse. The goal is to create an age-friendly environment and integrate the elderly into the mainstream, moving beyond a welfare-centric approach to one that recognizes their contributions and rights.
- Kerala is formulating a new draft policy specifically for its elderly population.
- Key proposals include a job registry for seniors and temporary shelters for abused elderly.
- The policy aims to ensure dignity, rights, and active participation of the elderly.
Haemophilia, a rare inherited bleeding disorder, causes excessive and spontaneous internal bleeding, leading to chronic disability and life-threatening situations. India faces a significant challenge with only 20% of estimated cases diagnosed due to lack of awareness and facilities, leaving many vulnerable. Untreated bleeds reduce life expectancy and cause socio-economic burdens. Prophylaxis, or regular replacement therapy of deficient clotting factors, has emerged as the 'gold standard' treatment. Unlike on-demand therapy, prophylaxis proactively prevents bleeds, ensuring good joint health, maintaining mobility, enhancing quality of life, and reducing healthcare burdens. Increased awareness and access to prophylaxis are critical to ending under-diagnosis and preventable disabilities in India.
- Haemophilia is a rare inherited bleeding disorder causing excessive and spontaneous internal bleeding, leading to severe disability and life-threatening risks.
- India has a low diagnosis rate for haemophilia, with only 20% of estimated cases identified, due to lack of awareness and diagnostic facilities.
- Untreated haemophilia bleeds significantly reduce life expectancy and impose substantial socio-economic challenges.
Groundwater contamination in India has escalated into a national public health crisis, threatening millions. The 2024 CGWB report reveals widespread contamination by nitrates, fluoride, arsenic, uranium, and heavy metals, leading to chronic illnesses like skeletal fluorosis, cancer, and neurological disorders. This crisis is attributed to systemic neglect, weak enforcement, fragmented regulatory systems, and over-extraction. The Water (Prevention and Control of Pollution) Act, 1974, is inadequate for groundwater, and regulatory bodies like CGWB and SPCBs lack authority and resources. A bold, multi-dimensional strategy is needed, including a national framework, modern monitoring, targeted remediation, and citizen-centric governance, to ensure safe and sustainable groundwater.
- Groundwater contamination in India has become a national public health crisis, affecting millions with chronic illnesses.
- The 2024 CGWB report highlights widespread contamination by nitrates, fluoride, arsenic, uranium, and heavy metals.
- Contamination leads to severe health issues such as skeletal fluorosis, various cancers, and neurological disorders.
Union Minister Jitendra Singh stated that 'riverine inputs' and abandoned, lost, and discarded fishing gear (ALDFG) are the primary sources of microplastic pollution along India's coasts. Field surveys by the National Centre for Coastal Research (NCCR) under the Ministry of Earth Sciences (MoES) confirmed this, covering transects along both east and west coasts. Microplastics, tiny plastic particles ranging from 1 micrometre to 5 millimetres, are a major concern due to their increasing links to tumors and toxicity to marine and aquatic life. The Food Safety and Standards Authority of India (FSSAI) has commissioned a project to assess microplastic contamination in food products.
- Riverine inputs and abandoned, lost, and discarded fishing gear (ALDFG) are identified as major sources of microplastic pollution on Indian coasts.
- Surveys by the National Centre for Coastal Research (NCCR) confirmed these findings across India's east and west coasts.
- Microplastics are tiny plastic particles (1 micrometre to 5 millimetres) formed from primary sources or breakdown of larger plastics.
The article highlights that India's official COVID-19 death toll significantly undercounts the true impact, as revealed by Civil Registration System (CRS) data showing a substantial rise in all-cause mortality during the pandemic years. In 2021, COVID-19 was the second leading cause of death, with 5.74 lakh certified fatalities, already exceeding the official figure, but this was based on less than a quarter of registered deaths. Systemic deficiencies like unregistered deaths, lack of medical certification (45% of deaths in 2020 had no medical attention), and misclassification obscure the true toll. Indirect deaths due to systemic disruptions further complicate the picture. The authors call for a systematic inquiry and reform of India's mortality surveillance architecture.
- Official COVID-19 death figures in India significantly undercount the true mortality impact, as indicated by Civil Registration System (CRS) data.
- Systemic deficiencies, including unregistered deaths and a lack of medical certification for a large percentage of fatalities, obscure the actual pandemic toll.
- Indirect deaths caused by pandemic-induced systemic disruptions further contribute to the undercounting.
The article critiques India's position in the India-United Kingdom Comprehensive Economic and Trade Agreement (CETA), specifically Article 13.6, which prioritizes voluntary mechanisms for access to medicines and technology transfer. This approach dilutes India's historical advocacy for compulsory licensing to ensure affordable medicines and its demand for technology transfer on favorable terms for developing countries. The authors argue that voluntary licenses are inadequate due to the weak bargaining power of domestic companies and limitations imposed by pharmaceutical corporations, citing past examples like the pricing of remdesivir and the compulsory license for sorafenib tosylate.
- The India-United Kingdom Comprehensive Economic and Trade Agreement (CETA) includes Article 13.6, which prioritizes voluntary mechanisms for access to medicines and technology transfer.
- This provision dilutes India's long-standing position favoring compulsory licensing for affordable medicines.
- India's demand for technology transfer on 'favourable terms' for industrialization and carbon footprint reduction is undermined.
Bio-fortified potatoes, enriched with iron, are set to enter Indian markets soon, with bio-fortified sweet potatoes (vitamin A added) already available in some states. The Peru-based International Potato Center (CIP) is establishing a South Asia regional centre in Agra, focusing on iron fortification in potatoes and collaborating with India's Central Potato Institute. The initiative aims to provide farmers with quality seeds, improve market access, and ensure vulnerable populations have access to nutritious potatoes, leveraging the Indo-Gangetic plains as the world's largest potato-producing area.
- Bio-fortified potatoes with added iron content will soon be available in Indian markets.
- The International Potato Center (CIP) is establishing its South Asia regional centre in Agra, India.
- Bio-fortified sweet potatoes with added vitamin A are already available in Karnataka, Assam, West Bengal, and Odisha.
The Tamil Nadu government is launching the 'Nalam Kakkum Stalin' program on August 2, offering a range of services through organized camps. State spokesperson J. Radhakrishnan announced that multiple departments, including Social Welfare, Women Empowerment, Labour Welfare, Skill Development, and Tribal Welfare, will participate. The camps will use bar codes for sample identification, with results available by day's end. A committee led by the Chief Secretary will review the program at the state level, while Collectors will oversee district-level implementation. Attendee details and test results will be fed into the Health Management Information System, accessible by hospitals, with weekly and monthly reviews of the program's functioning.
- Tamil Nadu's 'Nalam Kakkum Stalin' program will launch on August 2, providing various services through camps.
- Multiple government departments, including social welfare, labor, and tribal welfare, will be involved.
- The program emphasizes efficient data management, using bar codes for samples and feeding results into a Health Management Information System.
India aims to eliminate malaria by 2030, a goal complicated by hidden reservoirs, remote geographies, and parasite resistance. Despite an over 80% reduction in malaria burden between 2015-2023, tribal districts still show high rates. The article highlights the challenge of Plasmodium vivax, which causes relapses, and asymptomatic carriers. It discusses new vaccines like RTS,S (first approved, 2021) and R21/Matrix-M (WHO approved, 2023, with 77% efficacy), and the development of transmission-blocking vaccines (TBVs) like India's AdFalciVax. Innovative approaches include whole-parasite vaccines, engineered antibodies, and gene drives targeting mosquitoes, alongside the need for robust infrastructure and political will.
- India's ambitious goal to eliminate malaria by 2030 faces challenges from relapse-prone parasites, asymptomatic carriers, and remote regions.
- Significant progress has been made, with over 80% reduction in malaria burden between 2015 and 2023, but pockets of high incidence persist.
- New malaria vaccines, including RTS,S (approved 2021) and R21/Matrix-M (approved 2023 with 77% efficacy), offer promising tools.
A recent controversy has reignited the debate over the scope of medical activities for AYUSH practitioners, particularly their right to prescribe modern medicines and perform surgeries. Historically, the Bhore Committee (1946) favored modern medicine, but protests led to the Committee on Indigenous Systems of Medicine (1948), which linked Ayurveda to Hindu nationalism. The Indira Gandhi government enacted the Indian Medicine Central Council Act (1970), later replaced by the National Commission for Indian System of Medicine Act (2020), recognizing AYUSH. The core issue remains the interpretation of Rule 2(ee) of the Drugs and Cosmetics Rules, 1945, regarding who can prescribe modern medicine, with the Supreme Court in 1998 ruling against Ayurvedic practitioners prescribing allopathic drugs.
- The debate centers on AYUSH practitioners' scope, including prescribing modern medicines and performing surgeries.
- Historical committees like Bhore (1946) and Committee on Indigenous Systems of Medicine (1948) shaped the recognition of traditional medicine.
- Legislation like the Indian Medicine Central Council Act (1970) and the National Commission for Indian System of Medicine Act (2020) formally recognized AYUSH systems.
The article advocates for greater involvement of medical professionals in healthcare innovation, arguing that while engineers and entrepreneurs increasingly shape the future, doctors are often confined to service roles. It highlights that doctors, with their deep understanding of patient care and clinical workflows, are uniquely positioned to drive clinically applicable innovations. Obstacles like demanding practice, a risk-averse mindset, and a lack of exposure to financial management hinder doctors' entrepreneurial pursuits. The authors suggest integrating entrepreneurship, bio-design, and digital health into medical education, fostering interdisciplinary collaborations, and establishing innovation hubs to support doctor-led startups.
- Medical professionals, with their deep clinical understanding, are ideally positioned to lead innovation in healthcare.
- Current trends show engineers and entrepreneurs dominating healthcare innovation, sidelining doctors from creator roles.
- Barriers to doctor-led innovation include demanding practice, risk aversion, and lack of business exposure.
Experts warn that the U.K.-India Free Trade Agreement (FTA) contains intellectual property (IP) and regulatory clauses that could favor patent owners, potentially hindering the production and affordability of life-saving generic medicines. This could negatively impact patients in India and the Global South. Concerns include the preference for voluntary licenses, which often have restrictive conditions and fail to significantly reduce prices. The agreement also changes the submission of patent working details from annual to triennial and restricts public access to confidential information, making it harder to prove unmet demands for compulsory licenses.
- The U.K.-India FTA's IP and regulatory clauses are feared to favor patent owners, potentially limiting access to generic medicines.
- Provisions like the preference for voluntary licenses over compulsory ones raise concerns about drug affordability.
- Changes to patent working data submission (triennial instead of annual) and confidentiality will hinder proving unmet demands.
The India-U.K. Free Trade Agreement, while economically beneficial, poses significant public health risks for India. The deal's tariff-free entry for British High Fat, Sugar, and Salt (HFSS) food products could lead to lower prices, increased consumption, and a surge in diet-related diseases, mirroring Mexico's experience post-NAFTA. India's current regulatory framework for unhealthy foods is deemed sub-optimal, with weak enforcement of advertising restrictions and a preference for "star rating" front-of-pack nutrition labels over more effective warning labels. The article urges India to prioritize public health safeguards, including stricter advertising regulations and mandatory warning labels, to mitigate the adverse effects of cheaper junk food.
- The India-U.K. FTA, despite economic benefits, is criticized for potentially exacerbating public health issues in India by allowing cheaper HFSS food imports.
- The experience of Mexico post-NAFTA serves as a cautionary tale, where increased HFSS consumption led to a rise in diet-related diseases.
- India's existing regulations for unhealthy food advertising and labelling are considered inadequate compared to the UK's stricter norms.
More than 100 aid and human rights organizations, including Doctors Without Borders and Save the Children, have issued a dire warning about "mass starvation" spreading in Gaza. They called for an immediate negotiated ceasefire, the opening of all land crossings, and the free flow of aid through UN-led mechanisms. The U.S. envoy is heading to Europe for talks on a possible ceasefire and aid corridor amidst mounting international pressure on Israel over the catastrophic humanitarian situation. Warehouses full of supplies remain inaccessible, and children are reportedly dying of starvation, highlighting the critical failure of political commitments to deliver access to over two million people.
- Over 100 NGOs have issued a severe warning about widespread starvation in Gaza.
- They demand an immediate ceasefire, open land crossings, and unimpeded aid flow via UN mechanisms.
- International pressure is mounting on Israel due to the dire humanitarian crisis affecting over two million people.
The article argues for a paradigm shift from live animal testing to artificial biological models, citing ethical concerns and the unreliability of animal test results for human harm prediction. It highlights the suffering animals endure and proposes that advancements in tissue engineering allow for the cultivation of various artificial anatomical parts, making animal-free experimentation feasible. The author suggests amending 'The Prevention of Cruelty to Animals Act, 1960' to mandate the consideration of lab-grown models. The piece also calls for a change in societal values and increased awareness of animal suffering, advocating for the use of visual and ex-corpus models in education and research for safety testing.
- Animal testing is ethically problematic and often unreliable for predicting harm to humans.
- Advances in tissue engineering enable the creation of artificial anatomical parts for experimentation.
- The author proposes amending the Prevention of Cruelty to Animals Act, 1960, to prioritize lab-grown models.
A social audit commissioned by the Union government revealed that over 90% of workers who died in sewer and septic tank cleaning in 2022 and 2023 lacked safety gear or Personal Protective Equipment (PPE) kits. Out of 54 deaths examined, 47 workers had no equipment, and only a few had minimal gear like gloves or gumboots. The audit also found that in 27 cases, workers' informed consent was not taken, and in 45 deaths, agencies lacked equipment readiness. These findings highlight the severe lack of safety protocols despite the government's declaration that manual scavenging has ended, prompting the launch of the NAMASTE scheme to address hazardous cleaning.
- A social audit found that 90% of workers who died in sewer cleaning incidents in 2022-2023 lacked safety gear.
- Informed consent was not obtained from workers in a majority of the cases, and agencies lacked equipment readiness.
- Most workers were contracted personally or individually, rather than being formally employed.
Gujarat has initiated India's first Tribal Genome Sequencing Project to enhance tribal healthcare. The project aims to sequence the genomes of 2,000 individuals from tribal communities across 17 districts in the state. This initiative will focus on early detection and targeted treatment of genetic disorders prevalent in these communities, such as sickle cell anaemia, thalassemia, and certain hereditary cancers. Additionally, the genetic data collected will be utilized to identify markers related to natural immunity and to support the development of personalized healthcare solutions tailored for tribal populations.
- Gujarat has launched India's first Tribal Genome Sequencing Project to improve healthcare for tribal communities.
- The project will sequence the genomes of 2,000 individuals from tribal communities across 17 districts in Gujarat.
- Its primary goal is the early detection and targeted treatment of genetic disorders like sickle cell anaemia, thalassemia, and hereditary cancers.
The Health Ministry's initiatives to display oil, sugar, and trans-fat content in Indian snacks and establish 'sugar boards' in schools are welcome steps to raise awareness about unhealthy food consumption. These efforts are driven by increasing obesity trends, with NFHS data showing obesity rose from 15% to 24% in men and 12% to 23% in women between 2005-06 and 2019-21. However, the article argues that awareness alone is insufficient without essential legislative measures, such as clear front-of-package labels for packaged foods and additional taxes on high fat, sugar, and salt (HFSS) products. It emphasizes the need for FSSAI to define upper limits for sugar, salt, and fat to implement effective labelling.
- Health Ministry initiatives aim to raise awareness about unhealthy food content in Indian snacks and reduce sugar intake among children.
- Obesity trends in India show a significant increase, with NFHS data indicating a rise from 15% to 24% in men and 12% to 23% in women between 2005-06 and 2019-21.
- Awareness campaigns, while useful, are deemed insufficient without robust legislative measures to drive behavioral changes.
A fresh Nipah case in Kerala's Palakkad district, resulting in the death of a 58-year-old man, has triggered fears about the virus's continued presence and prompted an alert in six districts. Health authorities in Palakkad and Malappuram swiftly initiated contact tracing for 46 individuals who interacted with the victim. This incident marks the sixth Nipah case in Kerala within a year. Districts like Kozhikode, Thrissur, Kannur, and Wayanad have also been put on alert, with 543 persons across Kerala currently under observation. The National Institute of Virology (NIV), Pune, confirmed the case, highlighting the ongoing public health challenge.
- A recent Nipah case in Palakkad, Kerala, led to a death and subsequent health alert in six districts.
- Health authorities initiated rapid contact tracing for individuals who had interacted with the deceased.
- This is the sixth Nipah case reported in Kerala within the last year, indicating a recurring public health challenge.
India's first indigenous tetravalent dengue vaccine, DengiAll, developed by Panacea Biotec and supported by the Indian Council of Medical Research (ICMR), is nearing completion of its third phase clinical trials. Approximately 8,000 out of 10,000 targeted participants have enrolled across 20 centres nationwide. The vaccine aims to provide effective efficacy against all four dengue serotypes circulating in India. Dengue is a significant public health concern globally and in India, with high incidence and potential for severe conditions like hemorrhagic fever. Currently, there is no antiviral treatment or licensed vaccine for dengue in India.
- India's first indigenous tetravalent dengue vaccine, DengiAll, is undergoing Phase 3 clinical trials.
- The trials are a collaborative effort between the Indian Council of Medical Research (ICMR) and Panacea Biotec Ltd.
- The vaccine aims to provide efficacy against all four serotypes of the dengue virus, which co-circulate in India.